Molecular basis of pyruvate transport and inhibition of the human mitochondrial pyruvate carrier

The mitochondrial pyruvate carrier transports pyruvate, produced by glycolysis from sugar molecules, into the mitochondrial matrix, as a crucial transport step in eukaryotic energy metabolism. The carrier is a drug target for the treatment of cancers, diabetes mellitus, neurodegeneration, and metabolic dysfunction-associated steatotic liver disease. We have solved the structure of the human MPC1L/MPC2 heterodimer in the inward- and outward-open states by cryo-electron microscopy, revealing its alternating access rocker-switch mechanism. The carrier has a central binding site for pyruvate, which contains an essential lysine and histidine residue, important for its ΔpH-dependent transport mechanism. We have also determined the binding poses of three chemically distinct inhibitor classes, which exploit the same binding site in the outward-open state by mimicking pyruvate interactions and by using aromatic stacking interactions.

Authors

Institutions

Publication Details

Journal
Science Advances
Published
2025-04-18
DOI
https://doi.org/10.1126/sciadv.adw1489
Citations
12
Primary Topic
Mitochondrial Function and Pathology
Type
article
Field-Weighted Citation Impact
9.67
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Molecular basis of pyruvate transport and inhibition of the human mitochondrial pyruvate carrier

Jan Steyaert, Els Pardon, Sotiria Tavoulari, Shane M. Palmer et al.
12 citations
Science Advances
Mitochondrial Function and Pathology
9.67
article

Molecular basis of pyruvate transport and inhibition of the human mitochondrial pyruvate carrier

Jan Steyaert, Els Pardon, Sotiria Tavoulari, Shane M. Palmer, Jonathan J. Ruprecht, Lee R. Cooper, Denis Lacabanne, Giulia Paris, Mariangela Dionysopoulou, Ian M. Fearnley, Vanessa Leone, Dimitri Y. Chirgadze, Steven W. Hardwick, Edmund R.S. Kunji, Lucy R. Forrest, Martin King, Scott A. Jones, Alice P. Sowton, Maximilian Sichrovsky, Shujing Ding, Klaudia Stanik, J. L. Rana
article en
12 citations

Abstract

The mitochondrial pyruvate carrier transports pyruvate, produced by glycolysis from sugar molecules, into the mitochondrial matrix, as a crucial transport step in eukaryotic energy metabolism. The carrier is a drug target for the treatment of cancers, diabetes mellitus, neurodegeneration, and metabolic dysfunction-associated steatotic liver disease. We have solved the structure of the human MPC1L/MPC2 heterodimer in the inward- and outward-open states by cryo-electron microscopy, revealing its alternating access rocker-switch mechanism. The carrier has a central binding site for pyruvate, which contains an essential lysine and histidine residue, important for its ΔpH-dependent transport mechanism. We have also determined the binding poses of three chemically distinct inhibitor classes, which exploit the same binding site in the outward-open state by mimicking pyruvate interactions and by using aromatic stacking interactions.

Science AdvancesVol. 11(16)
Vrije Universiteit Brussel (BE), Medical College of Wisconsin (US), University of Cambridge (GB), National Institute of Neurological Disorders and Stroke (US), VIB-VUB Center for Structural Biology (BE), MRC Mitochondrial Biology Unit (GB)
Good health and well-being
Openalex Percentile: Top 2%
Mitochondrial Function and Pathology
9.67
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.